2026– date –
-
HHS Launches Cross-Agency Initiative to Restore US Clinical Trial Leadership, Leveraging AI/ML for Enhanced Safety & Efficiency
HHS.gov USA Overview The U.S. Department of Health and Human Services (HHS) has launched a landmark cross-agency initiative to restore the nation's leadership in clinical trials. This effort integrates artificial intelligence (AI) and ma... -
ClinicalTrials.gov Completes Modern Platform Migration, Dramatically Elevating Clinical Trial Data Access and Transparency
ClinicalTrials.gov USA Overview ClinicalTrials.gov has successfully transitioned to a modernized Protocol Registration and Results System (PRS) platform, significantly enhancing the accessibility and transparency of clinical trial inform... -
FDA Greenlights 24 Drugs in May 2026, Featuring AbbVie’s Decnupaz ADC and Shionogi’s Xocova COVID-19 Oral
BioWorld USA Overview The U.S. FDA approved 24 drugs in May 2026, marking the highest number of approvals in a single month this year, with eight being novel molecular entities (NMEs). This surge includes AbbVie's CD123-targeting antibod... -
FDA Greenlights Breakthrough TNBC Therapies, First-in-Class Hypertriglyceridemia Drug, and New Breast Cancer Maintenance Regimen
FDA USA Overview On June 24, 2026, the U.S. FDA announced pivotal approvals across several cancer and metabolic disease indications, introducing significant new therapeutic options. These include a breakthrough for triple-negative breast... -
Oral GLP-1 Aleniglipron Achieves 12% Weight Loss in Phase II, Poised to Transform Obesity Treatment
Health and Me / Northwestern University USA Overview The novel oral GLP-1 receptor agonist, aleniglipron, demonstrated an impressive average 12% body weight reduction over 36 weeks in obese or overweight patients during a Phase II clinic... -
Murata Manufacturing Enhances All-Solid-State Microbattery Energy Density and Cycle Life for Wearables
EE Times Japan Japan Overview Murata Manufacturing has updated its progress in all-solid-state microbattery technology, targeting small electronic devices and wearables. The company reported improvements in energy density and cycle life ... -
SES AI Expands U.S. R&D Facility to Accelerate Hybrid Lithium Metal Battery Development
Bloomberg USA Overview SES AI, a developer of hybrid lithium metal batteries, has announced a significant expansion of its research and development facility in the United States. This expansion will accelerate the development and scaling... -
Toppan’s Precision Coating Breakthrough Paves Way for Solid-State Battery Mass Production
凸版印刷ホールディングスプレスリリース Japan Overview Toppan Holdings has developed a novel high-precision coating technology for the uniform, ultra-thin deposition of solid electrolytes, a critical component in next-generation all-solid... -
Cold Pressing Techniques Advance Solid-State Battery Production, Significantly Reducing Cost and Energy
Journal of The Electrochemical Society Global Overview A new study in the Journal of The Electrochemical Society details significant advancements in cold pressing techniques for all-solid-state battery cell fabrication. Optimized cold pr... -
Horizon Europe Funds Major Project to Advance Bipolar Solid-State Battery Architectures
欧州委員会プレスリリース Europe Overview The European Union's Horizon Europe program has awarded substantial funding to a new international research project focused on advancing bipolar solid-state battery (SSB) architectures. This multi...
